DavidFeifelMDPhD

Clinical Trials

• Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes Start of enrollment: 2006 Dec 01

  Completed

  Phase 4

• Oxytocin Add on Study for Stable Schizophrenic Patients Start of enrollment: 2008 Mar 01

  Terminated

  Not Applicable

• Oxytocin Add-on Study for Stable Anxiety Patients Start of enrollment: 2009 Feb 01

  Terminated

  Not Applicable

• Oxytocin Add-on for Stable Depressed Patients Start of enrollment: 2010 Oct 01

  Terminated

  Not Applicable

• Antipsychotic Effects of Oxytocin Start of enrollment: 2011 Jun 01

  Terminated

  Not Applicable

• Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation. Start of enrollment: 2014 Aug 20

  Completed

  Phase 3

• Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia Start of enrollment: 2012 Mar 01

  Terminated

  Not Applicable

• A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD) Start of enrollment: 2016 Nov 17

  Terminated

  Not Applicable

• Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder Start of enrollment: 2017 Nov 27

  Completed

  Not Applicable

• Testing the Value of Smartphone Assessments of People With Mood Disorders Start of enrollment: 2017 Aug 08

  Completed

• Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology Start of enrollment: 2018 May 01

  Recruiting

• The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression Start of enrollment: 2019 Mar 01

  Completed

  Phase 2

• Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD) Start of enrollment: 2019 Aug 26

  Recruiting

• The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression Start of enrollment: 2020 Aug 10

  Completed

  Phase 2

• Join now to see all